PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Brigham researchers develop SCENT for genetic mapping of autoimmune diseases

2024-04-09
(Press-News.org) Genetic studies of diseases map segments of the genome driving disease. But to understand how those changes contribute to disease progression, it is important to understand how they may alter gene regulation of disease genes in cell populations assumed to be driving disease. “Enhancer-gene maps” link genomic regulatory regions to genes and are essential for understanding disease. But constructing them poses challenges due to limitations in current experimental methods, that make it difficult to apply the technique to rare cell populations and genes that only regulate specific cell types.

Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have developed a statistical method called SCENT (single-cell enhancer target gene mapping). This method uses multimodal single-cell data to establish links between regulatory elements and genes, allowing them to pinpoint probable causal gene loci for both common and rare diseases. These insights might assist the development of treatments for various conditions.

The research team applied SCENT to nine multimodal single-cell datasets representing various human tissues, including immune, neuronal, and pituitary cells, aiming to understand the intricacies of DNA regulation in each specific cell type. With these data, they developed 23 distinct gene-enhancer maps, to investigate genetic variants and expression patterns associated with 1,143 diseases and traits. Notably, they discovered that, for immune diseases, crucial insights emerged not only from immune cells but also from cells within the affected tissues themselves.

“For most autoimmune diseases, people assume that we need a general map of immune cells. But we find that the enhancer-gene maps of immune cells are different in affected disease tissues,” said Soumya Raychaudhuri, MD, PhD, of the Brigham’s Division of Rheumatology, Immunology and Inflammation. “We demonstrate how such a map can be used to interpret genetic data from rheumatoid arthritis and other autoimmune diseases.”

Read More in Nature Genetics.

END


ELSE PRESS RELEASES FROM THIS DATE:

Cognitive decline may be detected using network analysis, according to Concordia researchers

Cognitive decline may be detected using network analysis, according to Concordia researchers
2024-04-09
We all lose our car keys or our glasses from time to time. Most people would be correct to laugh it off as a normal part of aging. But for others, cognitive decline may start as a worrying but clinically unnoticeable step toward cognitive impairment, be it relatively mild or as severe as Alzheimer’s disease. The vast complexity of the human brain makes early diagnosis of cognitive decline difficult to achieve, which has potentially important implications for treatment and prevention. This is especially true ...

Clinical trial finds nasal spray safely treats recurrent abnormal heart rhythms

2024-04-09
A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms. The study, published March 25 in the Journal of the American College of Cardiology, provides real-world evidence that a wide range of patients can safely and effectively use the experimental drug, called etripamil, to treat recurrent paroxysmal supraventricular ...

FAU lands $1.3 million grant to ‘clean up’ stinky seaweed in Florida

FAU lands $1.3 million grant to ‘clean up’ stinky seaweed in Florida
2024-04-09
In the last decade, the emergence of a massive expanse of Sargassum, the Great Atlantic Sargassum Belt, has wreaked havoc on ecosystems and economies throughout the Caribbean. Conversely, this stinky brown seaweed provides vital habitats for marine life including loggerhead sea turtles. One of the worst invasions of Sargassum in recent history, especially for Florida, occurred in 2022 and potential impacts this year are yet to be determined. Decomposing Sargassum produces hydrogen sulfide and ammonia, which can result in potential human and environmental health impacts. Once Sargassum deluges beaches, removing, disposing and repurposing the seaweed presents many logistical ...

Breeding more resilient soybeans may come down to test site selection

Breeding more resilient soybeans may come down to test site selection
2024-04-09
URBANA, Ill. — In the quest to optimize crop productivity across environments, soybean breeders test new cultivars in multiple locations each year. The best-performing cultivars across these locations are selected for further breeding and eventual commercialization. However, a new study from the University of Illinois Urbana-Champaign suggests current soybean testing locations may not be delivering breeders the biggest bang for their buck.  “We met with most of the soybean breeders in public research universities across the Midwest and asked where they set up their trials over the last 30 to 40 years,” said Nicolas Martin, ...

Morphine tolerance results from Tiam1-mediated maladaptive plasticity in spinal neurons

Morphine tolerance results from Tiam1-mediated maladaptive plasticity in spinal neurons
2024-04-09
BIRMINGHAM, Ala. – Morphine and other opioids are vital to treat severe and chronic pain. However, they have two problems — prolonged use creates morphine tolerance, where ever-increasing doses are needed for the same pain relief, and paradoxically, prolonged use also can create an extreme sensitivity to pain, called hyperalgesia. Researchers at the University of Alabama at Birmingham and Baylor College of Medicine, Houston, Texas, now have shown that blocking the activity of an enzyme called Tiam1 in certain ...

USC-led study leverages artificial intelligence to predict risk of bedsores in hospitalized patients

2024-04-09
Bedsores—also known as pressure injuries—are the fastest rising hospital-acquired condition, according to the U.S. Agency for Healthcare Research in Quality, and as a result have become the second most common reason for medical malpractice suits in the United States.  Although most hospital-acquired pressure injuries are reasonably preventable, approximately 2.5 million individuals in the United States develop a pressure injury in acute care facilities every year, and 60,000 die. The total annual cost for U.S. health systems to manage the acute needs of patients’ ...

IADR announces recipients of the 2024 IADR LION Dental Research Award

2024-04-09
Alexandria, VA, USA – The International Association for Dental, Oral, and Craniofacial Research (IADR) has announced three recipients of the 2024 IADR LION Dental Research Award. The recipients were recognized during the Opening Ceremonies of the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA. The recipients are: Andrea Escalante Herrera University of ...

Cher Farrugia and Wei Qiao named winners of the 2024 IADR STAR Network Academy Fellowship

2024-04-09
Alexandria, VA, USA – The International Association for Dental, Oral, and Craniofacial Research (IADR) has announced Cher Farrugia and Wei Qiao as the winners of the 2024 IADR STAR Network Academy Fellowship. Farrugia, from the University of Bristol, England, UK, and Qiao, from  The University of Hong Kong, SAR, China, were recognized during the Opening Ceremonies of the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual ...

Fiorella Ventura named winner of the 2024 IADR Norton Ross Fellowship

2024-04-09
Alexandria, VA, USA – The International Association for Dental, Oral, and Craniofacial Research (IADR) has announced Fiorella Ventura as the winner of the 2024 IADR Norton Ross Fellowship. Ventura, from the University of Buenos Aires, Argentina, was recognized during the Opening Ceremonies of the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for ...

Diep Ha named winner of the 2024 IADR John Clarkson Fellowship

2024-04-09
Alexandria, VA, USA – The International Association for Dental, Oral, and Craniofacial Research (IADR) has announced Diep Ha as the winner of the 2024 IADR John Clarkson Fellowship. Ha, from The University of Queensland, Australia, was recognized during the Opening Ceremonies of the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA. Ha is a dentist and a Senior Research Fellow at the University ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Brigham researchers develop SCENT for genetic mapping of autoimmune diseases